Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

US Clinical Labs To Lose Money On COVID-19 Testing Without $5Bn Set Aside In Third $1Tn Aid Bill

Mar 20 2020

• By Sue Darcey

Financing of medicine and pharmaceuticals in connection with the coronavirus. Allocation of additional funds to fight the new virus. Increasing the profits of pharmaceutical companies.

Related Content

87635 Is AMA’s New CPT Code For Reporting COVID-19 Lab Testing

Mar 16 2020

COVID-19: FDA Eases Approval Policy By Allowing LDT Use Under ‘Immediately In Effect’ Guidance

Mar 01 2020

COVID-19: HHS Decree Looks To Shield Manufacturers From Future Liability Suits

Mar 17 2020

Additional Topics

United States Policy Coronavirus COVID-19 Safety Infectious Diseases In Vitro Diagnostics Medical Device

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window